Temporal arteritis medical therapy: Difference between revisions
No edit summary |
|||
| Line 8: | Line 8: | ||
==Medical Therapy== | ==Medical Therapy== | ||
==Pharmacotherapy== | ===Pharmacotherapy=== | ||
===Acute Pharmacotherapies=== | ====Acute Pharmacotherapies==== | ||
Prompt treatment with steroids is a medical emergency to reduce the risk of [[blindness]]. | Prompt treatment with steroids is a medical emergency to reduce the risk of [[blindness]]. | ||
Revision as of 13:10, 30 August 2012
|
Temporal Arteritis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Temporal arteritis medical therapy On the Web |
|
American Roentgen Ray Society Images of Temporal arteritis medical therapy |
|
Risk calculators and risk factors for Temporal arteritis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
Pharmacotherapy
Acute Pharmacotherapies
Prompt treatment with steroids is a medical emergency to reduce the risk of blindness.
Corticosteroids must be started as soon as the diagnosis is suspected (even before the diagnosis is confirmed by biopsy). Steroids do not prevent the diagnosis later being confirmed by biopsy, although certain changes in the histology may be observed towards the end of the first week of treatment and are more difficult to identify after a couple of months.[1]
A 3 day course of pulse steroids with 250 mg of IV solumedrol BID is critical in reducing the risk of permanent visual loss. If there is progression of visual loss on steroids, IV heparin can be administered to reduce the risk of thrombotic occlusion.
Treatment should not be deferred while waiting on the results of a temporal artery biopsy.
References
- ↑ Font RL, Prabhakaran VC (2007). "Histological parameters helpful in recognising steroid-treated temporal arteritis: an analysis of 35 cases". The British journal of ophthalmology. 91 (2): 204–9. doi:10.1136/bjo.2006.101725. PMID 16987903.